Walgreens Boots Alliance (WBA) reported sales of $34.3 billion for the third quarter of 2018, an increase of 14% from the same period last year. Sales rose 11.8% on a constant currency basis.
On a GAAP basis, net earnings attributable to Walgreens Boots Alliance grew 15.5% to $1.3 billion while EPS rose 26.2% to $1.35 compared with the prior-year period. Adjusted earnings totaled $1.5 billion or $1.53 per share, reflecting increases of 5.6% and 15% respectively from last year. Adjusted earnings figures beat analyst expectations but the stock fell 0.7% premarket.
During the quarter, sales for Retail Pharmacy USA increased 15% while comparable store sales dropped 1.2% from the prior-year period. US pharmacy sales grew 19%, driven primarily by higher prescription volume from the Rite Aid stores acquisition and from central specialty.
Retail Pharmacy International sales improved 6.6% and Pharmaceutical Wholesale sales grew 12.6% compared to the prior-year period.
Walgreens raised the lower end of its fiscal year 2018 outlook by $0.05 per share. The company expects adjusted diluted EPS to come in at $5.90 to $6.05 for the full year.
The board of directors authorized a $10-billion share repurchase program and also increased the quarterly dividend by 10% to $0.44 per share.
The market mayhem could not have come at a worse time for Bed Bath & Beyond Inc. (NASDAQ: BBBY). For long, the home furnishing retailer has been struggling, with a
Walgreens Boots Alliance (NASDAQ: WBA) reported third quarter 2020 earnings results today. Sales increased 0.1% year-over-year to $34.6 billion. Sales growth was 1.2% on a constant currency basis, led by
Amid the COVID-19 pandemic, several retailers were forced to close their stores but in turn witnessed a pickup in their digital business. Levi Strauss & Co. (NYSE: LEVI) is the